Sodium-Glucose Co-transporter 2 Inhibitors treatment improve pancreatic β-cells function and insulin resistance in patients with Type 2 diabetes

被引：1
|
作者：
Shi, Fang-Hong [1 ]
Xu, Li [2 ]
Shen, Long [2 ]
Cao, Min-Jia [1 ]
Li, Hao [3 ]
机构：
[1] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Pharm, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Cardiol, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Clin Res Ward, Clin Res Ctr, Shanghai Childrens Med Ctr,Sch Med, Shanghai, Peoples R China
来源：
EUROPEAN JOURNAL OF INTERNAL MEDICINE | 2024年 / 130卷
关键词：
DOUBLE-BLIND; SENSITIVITY;
D O I：
10.1016/j.ejim.2024.07.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：182 / 184
页数：3
相关论文
共 50 条
  • [21] Sodium-Glucose Co-Transporter 2 Inhibitors Reduce Macular Edema in Patients with Diabetes mellitus
    Tatsumi, Tomoaki
    Oshitari, Toshiyuki
    Takatsuna, Yoko
    Ishibashi, Ryoichi
    Koshizaka, Masaya
    Shiko, Yuki
    Baba, Takayuki
    Yokote, Koutaro
    Yamamoto, Shuichi
    LIFE-BASEL, 2022, 12 (05):
  • [22] How to position sodium-glucose co-transporter 2 inhibitors in the management of diabetes in acromegaly patients
    Adnan Zaina
    Nunzia Prencipe
    Elena Golden
    Alessandro Maria Berton
    Eldad Arad
    Ali Abid
    Jeryes Shehadeh
    Sameer Kassem
    Ezio Ghigo
    Endocrine, 2023, 80 : 491 - 499
  • [23] Sodium-Glucose Co-Transporter 2 Inhibitors and Fracture Risk
    Erythropoulou-Kaltsidou, Anastasia
    Polychronopoulos, Georgios
    Tziomalos, Konstantinos
    DIABETES THERAPY, 2020, 11 (01) : 7 - 14
  • [24] Sodium-Glucose Co-Transporter 2 Inhibitors and Heart Failure
    Gass, Alan
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (02): : S1 - S2
  • [25] Sodium-glucose co-transporter 2 inhibitors in heart failure
    Rosano, Giuseppe M. C.
    Vitale, Cristiana
    Savarese, Gianluigi
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (03) : E9 - E10
  • [26] Predictors for the Treatment Effect of Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes Mellitus
    Shusuke Yagi
    Ken-ichi Aihara
    Takeshi Kondo
    Kiyoe Kurahashi
    Sumiko Yoshida
    Itsuro Endo
    Daiju Fukuda
    Yutaka Nakaya
    Kin-ichiro Suwaki
    Takashi Takeji
    Toshihiro Wada
    Hotimah Masdan Salim
    Saori Hama
    Tomomi Matsuura
    Takayuki Ise
    Kenya Kusunose
    Koji Yamaguchi
    Takeshi Tobiume
    Hirotsugu Yamada
    Takeshi Soeki
    Tetsuzo Wakatsuki
    Munehide Matsuhisa
    Michio Shimabukuro
    Masashi Akaike
    Masataka Sata
    Advances in Therapy, 2018, 35 : 124 - 134
  • [27] Sodium-Glucose Co-Transporter 2 Inhibitors and Fracture Risk
    Anastasia Erythropoulou-Kaltsidou
    Georgios Polychronopoulos
    Konstantinos Tziomalos
    Diabetes Therapy, 2020, 11 : 7 - 14
  • [28] Sodium-glucose co-transporter 2 inhibitors and erythrocytosis: a review
    Shah, Najeeb
    Bandara, Thushari
    Deshmukh, Harshal
    Batten, Lucy
    Walton, Chris
    Sathyapalan, Thozhukat
    BRITISH JOURNAL OF DIABETES, 2022, 22 (02): : 73 - 77
  • [29] Harms and benefits of sodium-glucose co-transporter 2 inhibitors
    Chesterman, Thomas
    Thynne, Tilenka R. J.
    AUSTRALIAN PRESCRIBER, 2020, 43 (05) : 168 - 171
  • [30] Predictors for the Treatment Effect of Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes Mellitus
    Yagi, Shusuke
    Aihara, Ken-ichi
    Kondo, Takeshi
    Kurahashi, Kiyoe
    Yoshida, Sumiko
    Endo, Itsuro
    Fukuda, Daiju
    Nakaya, Yutaka
    Suwaki, Kin-ichiro
    Takeji, Takashi
    Wada, Toshihiro
    Salim, Hotimah Masdan
    Hama, Saori
    Matsuura, Tomomi
    Ise, Takayuki
    Kusunose, Kenya
    Yamaguchi, Koji
    Tobiume, Takeshi
    Yamada, Hirotsugu
    Soeki, Takeshi
    Wakatsuki, Tetsuzo
    Matsuhisa, Munehide
    Shimabukuro, Michio
    Akaike, Masashi
    Sata, Masataka
    ADVANCES IN THERAPY, 2018, 35 (01) : 124 - 134
12345